- Global Pharma News & Resources

Global Pharmaceutical Excipients Market is Expected to Reach at a CAGR of 5.93% from 2018 to 2025

A new research report published by Fior Markets with the title Pharmaceutical Excipients Market by Type (Organic Chemicals, inorganic Chemicals, Others), Functionality, Formulation, Regions, and Global Forecast 2018-2025.

As per the report, the global pharmaceutical excipients market is expected to grow from USD 6.17 Billion in 2017 to USD 9.78 Billion by 2025, at a CAGR of 5.93% during the forecast period from 2018-2025. The Europe region led the global pharmaceutical excipients market with a41.53% share of market revenue in 2017. However, the Asia Pacific region is expected to grow at an increased CAGR of 8.09% over the forecast period.


Major players in the global pharmaceutical excipients market are Ashland, BASF SE, DowDuPont, Roquette, Evonik, Associated British Foods, Archer Daniels Midland Company, Lubrizol, Croda, Innophous Holdings, Kerry Group, Wacker Chemie, Signet, Avantor Performance Materials, Inc., FMC Corporation, Colorcon, Inc., Eastman Chemical Corporation, P&G Chemicals, Huntsman Corporation, Merck, Valeant, JRS Pharma, Shin-Etsu Chemical Co., Ltd., DFE Pharma, Finar Limited, and among others. Major players focusing on improving their excipient product offerings. For instance, in 2017, DFE Pharma announced the launch of new specialty grade SuperTab® 40LL. This new product provides the possibility to comfortably run highly dosed formulations (e.g. mini-tablets) through processing machines directly compressible; at high speed with good content uniformity.

Type segment is divided into organic excipients, inorganic excipients, and others. The organic pharmaceutical excipients exhibit a significant property for delivering improved efficacy in oral delivery of poorly soluble molecules. They also provide the increased compressibility and flowability to the pharmaceutical formulations. Thus the organic pharmaceutical excipients segment led the global pharmaceutical excipients market with a 42.89% share of market revenue in 2017. The functionality segment contains fillers & diluents, binders, suspending & viscosity agents, flavoring agents & sweeteners, coating agents, colorants, disintegrants, lubricants & glidants, preservatives, emulsifying agents, and others. The fillers & diluents materials help in improving the taste of the formulation and provide the ease of administration coupled with providing the stability, ease in preparation, packaging, shipping, and dispensing of pharmaceutical drugs. Based on these factors the fillers & diluents segment emerged as the global leader in the pharmaceutical excipients market with a 32.28% share of market revenue in 2017. Formulation is segmented into oral formulations, topical formulations, parenteral formulations and others. Due to the increasing utilization of the parenteral route for delivering the biologics and biosimilars drugs, the parenteral formulations segment is projected to grow an accelerated CAGR of 7.72% over the forecast period.

Even though the factors such as global surge in the sale of generic drugs, rising use of biopharmaceuticals as well as rising geriatric population are driving the global pharmaceutical excipients market. The stringent regulatory approval process and cost and time intensive nature of the drug development process are expected to hold back the growth of the market over the forecast period.


About the report: 
The global pharmaceutical excipients market is analysed on the basis of value (USD Billion), volume (K Units), export (K Units), and import (K Units). All the segments have been analyzed on global, regional and country basis. The study includes the analysis of more than 30 countries for each segment. The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The study includes porter’s five forces model, attractiveness analysis, raw material analysis, and competitor position grid analysis.

Customization of the Report:
The report can be customized as per client requirements. For further queries, you can contact us on or +1-201-465-4211. Our executives will be pleased to understand your requirements and offer you the best-suited reports.

Contact Us
Mark Stone
Phone: +1-201-465-4211

This content has been distributed via CDN Newswire press release distribution service. For press release enquires please mail us at

Editor Details

  • Company:
    • CDN Newswire
Last Updated: 06-Jul-2020